Deina Walsh - Jan 17, 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Chief Financial Officer
Signature
/s/ Deina Walsh
Stock symbol
BBLG
Transactions as of
Jan 17, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 05:24 PM
Previous filing
Sep 14, 2023
Next filing
Jan 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BBLG Common Stock 1.88K Jan 17, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Employee Stock Option Award $0 +12.5K $0.00 12.5K Jan 17, 2024 Common Stock 12.5K $3.61 Direct F1
holding BBLG Employee Stock Option 78 Jan 17, 2024 Common Stock 78 $57.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
F2 This option is fully vested as of the date of this report.